Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
Clinical trial NCT00615901 · COMPLETED
Trial details
- NCT number
- NCT00615901
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-06-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.